Alvotech Ordinary Shares (ALVO) Stock Price

ALVOStock

$5.00−42.86%52W

Market Cap$1.78B

P/E69.92x

PEG Ratio—

Div yield—

Beta0.23

ALVO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)31.74%

Price vs S&P 500 (4W)-13.64%

VGM Score45.78

P/E Ratio (Annual)69.92x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)90.62%

Cash Flow / Share (Quarterly)$-0.94

Price vs S&P 500 (YTD)-14.46%

Gross Margin (TTM)60.66%

Net Profit Margin (TTM)-36.31%

EPS (TTM)$-0.63

10-Day Avg Trading Volume1.17M

EPS Excl Extra (TTM)$-0.63

Revenue Growth (5Y)53.35%

EPS (Annual)$0.10

Gross Margin (Annual)60.00%

Net Profit Margin (5Y Avg)-298.62%

Cash / Share (Quarterly)$0.40

P/E Basic Excl Extra (TTM)43.25x

Revenue Growth QoQ (YoY)-38.90%

P/E Normalized (Annual)69.92x

ROA (Last FY)1.88%

Revenue Growth TTM (YoY)-12.07%

EBITD / Share (TTM)$0.33

Operating Margin (TTM)11.42%

Cash Flow / Share (Annual)$-0.47

Net Income / Employee (Annual)$19,100

EV / Revenue (TTM)6.59x

Net Interest Coverage (TTM)-0.02x

ROA (TTM)-12.17%

EPS Growth QoQ (YoY)-99.06%

EV / EBITDA (TTM)33.34x

EPS Incl Extra (Annual)$0.10

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.83x

3-Month Avg Trading Volume1.03M

52-Week Price Return-42.86%

P/E Incl Extra (TTM)43.25x

Revenue / Employee (TTM)$338,800

P/S Ratio (Annual)3.31x

Asset Turnover (Annual)0.40x

52-Week High$9.00

Operating Margin (5Y Avg)-207.16%

EPS Excl Extra (Annual)$0.10

CapEx CAGR (5Y)51.66%

26-Week Price Return41.64%

Quick Ratio (Annual)1.07x

13-Week Price Return44.51%

Current Ratio (Quarterly)1.65x

Enterprise Value$3.26B

Revenue / Share Growth (5Y)-1.88%

Asset Turnover (TTM)0.34x

Revenue / Employee (Annual)$403,400

Inventory Turnover (Annual)1.35x

Pretax Margin (Annual)23.15%

Cash / Share (Annual)$0.55

3-Month Return Std Dev79.92%

Net Income / Employee (TTM)$-123,000

Net Interest Coverage (Annual)0.61x

EPS Basic Excl Extra (Annual)$0.10

Receivables Turnover (TTM)3.66x

EPS Incl Extra (TTM)$-0.63

Receivables Turnover (Annual)3.26x

P/S Ratio (TTM)3.95x

Pretax Margin (5Y Avg)-348.62%

Revenue / Share (Annual)$2.02

Forward P/E40.04x

Price vs S&P 500 (52W)-58.39%

P/E Ratio (TTM)43.25x

Year-to-Date Return-2.53%

5-Day Price Return-9.09%

EPS Normalized (Annual)$0.10

ROA (5Y Avg)-30.83%

Net Profit Margin (Annual)4.74%

Month-to-Date Return-13.79%

EBITD / Share (Annual)$0.41

Operating Margin (Annual)17.64%

P/E Excl Extra (TTM)43.25x

EPS Basic Excl Extra (TTM)$-0.63

Inventory Turnover (TTM)1.02x

Pretax Margin (TTM)-6.50%

Price vs S&P 500 (13W)41.82%

Beta0.23x

Revenue / Share (TTM)$1.76

52-Week Low$2.94

vGradeD

gGradeD

mGradeB

vgmGradeC

ALVO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 19, 2026	-$0.08	-$0.11	-30.16%(-$0.03)
Q1 2026	May 6, 2026	-$0.07	-$0.09	-28.57%(-$0.02)
Q4 2025	Mar 18, 2026	-$0.01	$0.01	+190.83%(+$0.02)
Q3 2025	Nov 13, 2025	-$0.03	-$0.11	-230.93%(-$0.08)
Q2 2025	Aug 13, 2025	-$0.00	$0.03	+1410.04%(+$0.03)

ALVO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.92

3.91

4.00

Industry Peers — Biological Products(186)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ALVOAlvotech Ordinary Shares	D	D	B	3.9x	-12.1%	60.7%	—	$5.00
AMGNAmgen Inc	D	C	A	6.1x	9.1%	74.3%	2.9%	$432.49
GILDGilead Sciences Inc	C	B	A	6.4x	5.5%	79.6%	133.6%	$156.19
MRNAModerna, Inc. Common Stock	F	C	A	39.1x	-27.6%	36.4%	—	$218.01
ARGXargenx SE American Depositary Shares	D	A	B	6.6x	165.2%	89.8%	—	$819.14
RVMDRevolution Medicines, Inc. Common Stock	F	—	B	3296.2x	—	—	—	$177.96
BIIBBiogen Inc. Common Stock	C	D	A	3.4x	0.3%	74.0%	-18.8%	$232.65
BNTXBioNTech SE American Depositary Share	C	C	C	7.6x	-11.8%	79.2%	—	$87.71
EXELExelixis Inc	C	B	A	6.3x	9.2%	96.5%	31.1%	$62.23
HALOHalozyme Therapeutics, Inc.	D	B	A	8.3x	41.1%	82.4%	22.9%	$121.84
NBIXNeurocrine Biosciences Inc	C	B	B	4.1x	34.4%	98.0%	2.3%	$135.71
TECHBio-Techne Corp.	D	C	B	9.4x	-0.4%	66.2%	6.0%	$72.57
RGENRepligen Corp	F	C	A	14.2x	16.5%	53.8%	-4.9%	$175.42
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	—	—	—	—	$135.07
PCVXVaxcyte, Inc. Common Stock	—	—	B	—	—	—	—	$63.62
IBRXImmunityBio, Inc. Common Stock	F	A	A	58.7x	192.9%	99.3%	—	$9.18
QGENQIAGEN N.V.	C	C	B	4.5x	3.0%	62.5%	4.2%	$46.13
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	21.3x	22.6%	94.6%	—	$316.58
TWSTTwist Bioscience Corporation Common Stock	D	B	A	20.2x	19.2%	52.0%	—	$132.75
KYMRKymera Therapeutics, Inc. Common Stock	F	B	B	83.0x	134.8%	—	—	$104.78
IOVAIovance Biotherapeutics, Inc. Common Stock	D	B	A	19.0x	34.5%	48.4%	—	$13.62
IMVTImmunovant, Inc. Common Stock	—	—	C	—	—	—	—	$26.73
KODKodiak Sciences Inc Common Stock	—	—	A	—	—	—	—	$85.75
CGONCG Oncology, Inc. Common stock	F	A	B	851.8x	1030.3%	-85.2%	—	$59.85
SRRKScholar Rock Holding Corporation Common Stock	F	—	C	102.7x	—	—	—	$39.90
CRSPCRISPR Therapeutics AG	D	B	B	355.6x	-64.8%	—	—	$49.25
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	B	12.4x	50.1%	75.6%	—	$24.02
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	344.7x	23.9%	—	—	$16.28
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	5.5x	105.2%	93.3%	—	$68.07
DNLIDenali Therapeutics Inc. Common Stock	F	—	C	781.1x	—	—	—	$17.61
BEAMBeam Therapeutics Inc. Common Stock	D	B	C	15.5x	158.9%	—	—	$23.47
ADMAADMA Biologics, Inc.	C	C	B	4.7x	8.0%	64.7%	—	$10.68
VCELVericel Corporation	D	B	B	6.7x	22.9%	74.6%	38.9%	$40.13
BCRXBioCryst Pharmaceuticals Inc	B	A	B	2.1x	68.7%	97.8%	—	$7.79
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	33.9x	-15.1%	3.5%	—	$3.46
NVAXNovavax Inc	C	D	B	4.5x	-61.6%	79.2%	—	$11.26
MESOMesoblast Limited American Depositary Shares	D	A	C	14.6x	599.2%	86.1%	—	$13.28
VIRVir Biotechnology, Inc. Common Stock	B	B	B	5.6x	1496.1%	100.0%	—	$9.96
MAZEMaze Therapeutics, Inc. Common Stock	—	A	B	—	700.0%	—	—	$27.53
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	3.5x	20.9%	98.9%	—	$29.40
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	C	—	—	—	—	$30.07
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	944.3x	550.0%	—	—	$89.83
TSHATaysha Gene Therapies, Inc. Common Stock	D	C	D	120.7x	-32.3%	—	—	$3.62
IMTXImmatics N.V. Ordinary Shares	C	C	C	21.5x	-68.0%	—	—	$6.73
REPLReplimune Group, Inc.	—	—	B	—	—	—	—	$10.86
VORVor Biopharma Inc. Common Stock	—	—	C	—	—	—	—	$18.03
MGTXMeiraGTx Holdings plc Ordinary Shares	C	A	C	2.2x	948.4%	98.0%	—	$9.28
SLBTSL Science Holding Limited Ordinary Shares	—	—	D	—	—	—	—	$1.53
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	C	—	—	—	—	$12.93
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	D	28.9x	-83.9%	—	—	$9.74
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	B	168.6x	-19.0%	—	—	$17.17

About Alvotech Ordinary Shares

Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines. The company creates affordable alternatives to existing biologic therapies, expanding patient access to treatments while leveraging its integrated research, development, and manufacturing capabilities.